Clinical Trial Update: Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intrauterine versus sublingual misoprostol plus oxytocin for preventing post-cesarean hemorrhage in high-risk pregnant women has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section Complications
• High-risk Pregnancy
• Postpartum Hemorrhage
• Postpartum Hemorrhage Due to Cesarean Section

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women | Phase 3 | Status: COMPLETED